DBV Technologies S.A. (NASDAQ: DBVT) shares jumped 27.36% to $4.19 on the US stock charts during Wednesday’s after-hours trade. The cause for that spike in DBVT stock price was the disclosure of significant regulatory advancements with the U.S. Food and Drug Administration (FDA) concerning their Viaskin Peanut patch product. Faster Approval Process Successful written and […]
After-Market Gains For DBV Technologies (DBVT) Stock Read More »
Frequency Electronics, Inc. (NASDAQ: FEIM) had exceptional financial performance in the second quarter of fiscal year 2025. And that is propelling FEIM shares on the US stock charts today, sending them up 33.31% to $17.05 as of the last check. Exceptional Financial Performance Frequency Electronics (FEIM) reported quarterly revenue of approximately $15.8 million and a
Frequency Electronics (FEIM) Stock Climbs On Strong Financial Results Read More »
After Patterson Companies, Inc. (NASDAQ: PDCO) announced a final deal to be bought by Patient Square Capital, a healthcare-focused investment group, the company’s shares shot up 34.40% to $31.06. A cash offer of $31.35 per share, or 49% more than PDCO’s 30-day volume-weighted average price (VWAP) ending December 4, 2024, is part of the purchase
Patterson (PDCO) Shares Surge Following Acquisition Agreement Read More »
LeddarTech Holdings Inc. (NASDAQ: LDTC) shares are on a remarkable upswing, with shares trading 77.68% higher at $2.15 as of the latest check today. This surge began earlier this week following the announcement of a pivotal strategic collaboration agreement. Strategic Partnership with Texas Instruments LeddarTech (LDTC) announced that it has entered into a software license
Stock Surge For LeddarTech (LDTC): Strategic Alliance Fuels Growth Read More »
With the release of encouraging primary endpoint findings from its phase 3 clinical study assessing CAN-2409 viral immunotherapy in localized prostate cancer, Candel Therapeutics, Inc. (NASDAQ: CADL) has reached a noteworthy milestone. The shares of CADL jumped 144.61% after this statement, trading at $11.28 as of the latest market check. A landmark Results of the
Candel (CADL) Stock Skyrockets Following Major Clinical Trial Milestone Read More »
On Tuesday, Shares of Quantum-Si Incorporated (NASDAQ: QSI) surged significantly, rising 13.57% during the regular trading session to close at $2.26, followed by a 10.62% after-hours increase to $2.50. This momentum was sparked by the company’s recent unveiling of innovative protein sequencing tools, highlighting its commitment to advancing proteomic research. Introducing the Platinum Library Prep
Extended Session Momentum Drives Quantum-Si (QSI) Stock Read More »
Banzai International, Inc. (NASDAQ: BNZI) shares witnessed a remarkable 47.48% surge on the US stock charts, closing the Tuesday session at $2.05. This spike followed the announcement of its acquisition agreement with OpenReel, a prominent digital video creation platform. The deal underscores BNZI’s commitment to expanding its suite of marketing technology solutions. OpenReel: Revolutionizing Enterprise
Banzai (BNZI) Gains Investor Confidence Amid Acquisition Announcement Read More »
On Tuesday, the shares of Roadzen, Inc. (NASDAQ: RDZN) saw an incredible upswing, rising 57.56% to close at $2.60. This remarkable acquisition came after Motive, an AI-powered Integrated Operations Platform, announced a strategic alliance. The collaboration aims to revolutionize roadside assistance services, expanding Roadzen’s reach and influence across a wide customer base. Roadzen and Motive:
Roadzen’s (RDZN) Market Performance Soars On New Collaboration Read More »
After a successful AI calibration completion was announced, the stock price of Rigetti Computing Inc. (NASDAQ: RGTI) increased significantly. Shares have increased 43.27% to $6.40 as of the most recent check. A Significant Development in Quantum Computing Rigetti Computing (RGTI) reported a significant advancement in the realm of quantum computing in partnership with Quantum Machines.
Rigetti (RGTI) Stock Soars After Successful AI Quantum Achievement Read More »
Cardiff Oncology, Inc. (NASDAQ: CRDF) stock is rising remarkably on the US stock charts today. As of the latest check, CRDF shares were up 50.31%, trading at $3.67. This outstanding accomplishment comes after important announcements that showcase the business’s clinical and financial developments. Strategic Equity Offering Cardiff Oncology today revealed that 15,384,619 shares of company
Positive Stock Movement for Cardiff Oncology (CRDF) After Equity Offering Read More »
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.